Latest / The Best of the Money Show / SA imports 80% of medical devices despite local manufacturing capacity
Transcript
- 0:00Speaker 1: Well, the Localization Support Fund says they found nearly half
- 0:02Speaker 1: of our local companies in the medical space, people who
- 0:06Speaker 1: produce things that are used in the medical business, they're
- 0:10Speaker 1: actually using less than half of their capacity. 80% of
- 0:14Speaker 1: the medical appliances that we use are actually imported. I mean,
- 0:18Speaker 1: what a bizarre thing. Rashad Katrada is the Chief Executive
- 0:22Speaker 1: Officer of the Localization Support Fund. Rashad, good evening and
- 0:25Speaker 1: thanks for the time. We have a lot of capacity
- 0:27Speaker 1: in this space. We're clearly not using it. Is it
- 0:30Speaker 1: possible to work out why?
- 0:34Speaker 2: Good evening, Stephen, to you and your listeners, and thanks
- 0:36Speaker 2: so much for having me on the show. Look, I
- 0:38Speaker 2: think there are a couple of reasons that speak to
- 0:40Speaker 2: why we're not using all of that capacity. The first
- 0:43Speaker 2: really comes down to probably procurement, as it were. The
- 0:48Speaker 2: public sector still is a big buyer of medical devices.
- 0:52Speaker 2: And when we talk medical devices, we're talking everything from
- 0:54Speaker 2: the very high-tech CT scanners and MRIs to what would
- 0:59Speaker 2: be considered much more basic and expendable, the likes of
- 1:02Speaker 2: your sutures, gloves, and other such things that we have.
- 1:09Speaker 2: What we're finding across most of the public and the
- 1:11Speaker 2: private sector is that procurement is still relatively fragmented. And
- 1:13Speaker 2: that's very, very difficult then for local manufacturers to get behind.
- 1:17Speaker 2: You have short-term contracts that are very, very small volume
- 1:20Speaker 2: when really this is a massive market. We import about
- 1:23Speaker 2: 150 billion rands worth of medical technologies and devices over
- 1:26Speaker 2: a five-year period. So call it about a 30 billion
- 1:30Speaker 2: rand market per annum, 10 billion of which is in
- 1:32Speaker 2: the private sector alone. But that fragmentation doesn't allow the
- 1:36Speaker 2: manufacturers to reach the economies of scale. And that's one
- 1:38Speaker 2: of the key recommendations that's coming out of the work
- 1:40Speaker 2: that we have that we're hoping to institutionalize in the
- 1:43Speaker 2: master plan is that we need to be piloting across
- 1:46Speaker 2: the different spheres of government, be it your hospitals, your
- 1:50Speaker 2: provincial departments of health and national, key sort of buying programs.
- 1:54Speaker 2: And we've seen this work, you know, in the Western
- 1:56Speaker 2: Cape region. They've begun to implement longer contracts, and that's
- 2:00Speaker 2: helped manufacturers get behind it, even when you don't have
- 2:03Speaker 2: specified local content requirements.
- 2:06Speaker 1: I mean, the thing about medical things like sutures or
- 2:09Speaker 1: syringes or something like that is if you're a health
- 2:12Speaker 1: department for a province, you know you can forecast what
- 2:15Speaker 1: you're going to need over five years because you've got
- 2:17Speaker 1: so much information. So it shouldn't be hard to procure
- 2:21Speaker 1: on a bigger scale. Is there any particular reason why
- 2:23Speaker 1: that hasn't happened? And I mean, within that, there has
- 2:26Speaker 1: to be a question around whether the price of the
- 2:28Speaker 1: goods made here is any different to the imported stuff.
- 2:32Speaker 2: Yeah, so I mean, let's touch on price. I think
- 2:35Speaker 2: price is a concern in some instances, but part of
- 2:39Speaker 2: the work that we have done was engaging widely with
- 2:41Speaker 2: buyers in national government, in provincial government. What we find
- 2:44Speaker 2: is the pricing isn't the biggest problem and the biggest obstacle.
- 2:48Speaker 2: I think part of it is that we're not being
- 2:50Speaker 2: sufficiently strategic in the public sector when it comes to buying.
- 2:53Speaker 2: I think you're absolutely right. We ought to have the data.
- 2:56Speaker 2: And I say ought to have the data because one
- 2:58Speaker 2: of the interesting things that our research has found is
- 3:00Speaker 2: that the data itself is very, very scattered. Part of
- 3:03Speaker 2: work that we do like this is often holding up
- 3:05Speaker 2: a mirror to government saying, hang on guys, I don't
- 3:07Speaker 2: know if you know this, but this is the actual
- 3:09Speaker 2: level of procurement that you have across the state. It's
- 3:12Speaker 2: just unfortunately happening in a very fragmented way. Individual hospitals
- 3:16Speaker 2: will go off and they'll buy a certain amount. Provincial
- 3:18Speaker 2: departments will buy a certain amount. And the national government
- 3:21Speaker 2: might do similarly. Now, when you bring all of that together,
- 3:23Speaker 2: we're talking significantly large numbers, more than a billion rand
- 3:27Speaker 2: of sutures growing at 61% per annum. Because as you say,
- 3:31Speaker 2: these are areas that we need to look at. I
- 3:33Speaker 2: think probably another problem, and I've touched on procurement, is
- 3:35Speaker 2: obviously around regulation. What a lot of manufacturers are calling
- 3:39Speaker 2: out for is You know, just standardized, streamlined, and predictable regulation.
- 3:44Speaker 2: They're not saying that we shouldn't regulate. I think every
- 3:46Speaker 2: South African would stand firmly behind the idea that we
- 3:49Speaker 2: want to make sure that what we're using in hospitals
- 3:52Speaker 2: is appropriate and has gone through all the right kind
- 3:54Speaker 2: of testing. But a lot of the, you know, we
- 3:56Speaker 2: don't have a lot of testing and certification capability in
- 3:58Speaker 2: the country at the moment. And that's very, very difficult
- 4:01Speaker 2: to build. And it's something that the public sector ought
- 4:03Speaker 2: to be stepping in to build up because some of
- 4:06Speaker 2: the manufacturers, particularly for the higher technical equipment, are having
- 4:10Speaker 2: to send it abroad and test it there and then
- 4:12Speaker 2: re-import into the country, which obviously adds in cost, which
- 4:15Speaker 2: then would make it sort of unbankable for the public sector. No, sure.
- 4:19Speaker 1: I mean, and I presume if you've got the public
- 4:21Speaker 1: sector working on this, The private sector, which is also
- 4:24Speaker 1: pretty big, certainly for the higher end stuff, they would
- 4:27Speaker 1: follow because the price would go down almost automatically because
- 4:30Speaker 1: of the economy of scale.
- 4:33Speaker 2: Exactly, exactly. And I think that's where the study is
- 4:36Speaker 2: pointing to. So I think, you know, we recognize that
- 4:39Speaker 2: for some of the high technical equipment, your MRI, CT
- 4:43Speaker 2: scans I mentioned earlier. Those might be more challenging in
- 4:46Speaker 2: the short term. And I don't think we should give
- 4:47Speaker 2: up on it in the long term because what we've
- 4:49Speaker 2: seen in other markets, we've been able to move from
- 4:52Speaker 2: import and distribution to low levels of assembly. If we
- 4:55Speaker 2: feel that the market is getting big enough, we recognize
- 4:58Speaker 2: that the African market is growing as well, although South
- 5:00Speaker 2: Africa is still the most so that it can set
- 5:04Speaker 2: itself up as a manufacturing base that could that could
- 5:07Speaker 2: that could work but we got a pilot where we
- 5:09Speaker 2: have uh you know capability at in the beginning so
- 5:12Speaker 2: we've mentioned sutures we've mentioned syringes we've mentioned surgical gloves
- 5:16Speaker 2: but we're also looking at wheelchairs and and furniture um
- 5:20Speaker 2: you know a lot of the hospital furniture that you
- 5:22Speaker 2: find uh is being imported i mean that can very
- 5:25Speaker 2: easily be manufactured.
- 5:26Speaker 1: Locally i mean there'll be conversations with the health department
- 5:29Speaker 1: and other people and there's sort of a lot going
- 5:31Speaker 1: on in that space and presumably a shirt. None of
- 5:34Speaker 1: it will feature skinny jeans. Do you expect there to
- 5:37Speaker 1: be a big change?
- 5:40Speaker 2: Well, I'd like to think so. I mean, we did
- 5:42Speaker 2: this work in the context of a master plan that
- 5:44Speaker 2: was signed two years ago by stakeholders that brought government
- 5:47Speaker 2: together and private sector with the endeavor of growing the sector,
- 5:50Speaker 2: including the number of jobs in the sector. Now, ambition
- 5:53Speaker 2: doesn't become action if you don't have a strategy around it.
- 5:56Speaker 2: And part of the reason we did this work is
- 5:58Speaker 2: because we wanted government and stakeholders to understand what is
- 6:01Speaker 2: it that we're looking at, what's the short-term prizes that
- 6:03Speaker 2: we can focus in on. All of this has to
- 6:05Speaker 2: be institutionalized within these master plans. I think I've said
- 6:08Speaker 2: this on a new show before. These master plans are
- 6:11Speaker 2: nothing more but platforms of collaboration and coordination, and they're
- 6:14Speaker 2: only as good as the energy and effort that goes
- 6:17Speaker 2: into it. We've now sat down with the National Department
- 6:20Speaker 2: of Health, the Department of Trade, Industry, and Competition. We've
- 6:23Speaker 2: walked them through this. It's up to stakeholders to take
- 6:25Speaker 2: it forward. I mean, we can play our role as
- 6:28Speaker 2: localization support funders. We want to do, but we want
- 6:31Speaker 2: to make sure that it gets through. There's a massive opportunity,
- 6:33Speaker 2: and it's not just about job creation and economic growth,
- 6:36Speaker 2: which is very, very important, but it's also about resilience
- 6:39Speaker 2: of the healthcare system. And we don't want to be
- 6:40Speaker 2: in a position... like we were in COVID, waiting behind
- 6:43Speaker 2: very long lead times and queues to get essential medical
- 6:47Speaker 2: and technology services into the country.
- 6:50Speaker 1: Urshad Katrada, thanks so much. Really appreciate it. Chief Executive
- 6:53Speaker 1: Officer of the Localization Support Fund. In a moment, the
- 6:57Speaker 1: relationship between SARS and influencers. They're going to get closer.
- 7:01Speaker 1: It's seven o'clock.